Michael Postow

43PUBLICATIONS

277CO-AUTHORS

Predictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (43)

Sort by Publication Date:

|Jul 02, 2026

Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years.

|Jun 25, 2026

Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma.

|May 04, 2026

Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases.

|Mar 27, 2026

CD8 PET imaging with [<sup>89</sup>Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study.

Michael A Postow, Peter D Zang, Sumanta K Pal

|Mar 03, 2026

Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.

Tessa F Flores, Emily S Tonorezos, Shailender Bhatia

|Nov 28, 2025

International real-world study of combination immunotherapy sequences in metastatic melanoma.

Mora Guardamagna, Sarah E Lochrin, James William Smithy

Pageof 8

Frequent Collaborators

Alexander Shoushtari

Paolo A Ascierto

Ryan Sullivan

Jedd D Wolchok

Allison S Betof

Paul Chapman

James William Smithy

David M Faleck

Dirk Schadendorf

Margaret K Callahan

Frequent Collaborators

Alexander Shoushtari

Paolo A Ascierto

Ryan Sullivan

Jedd D Wolchok